Adipose-derived regenerative cells for treating liver injury
Abstract
Cells present in processed lipoaspirate tissue are used to treat patients. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the stem cells are not exposed to an external environment prior to being administered to a patient. Compositions that are administered to a patient include a mixture of adipose tissue and stem cells so that the composition has a higher concentration of stem cells than when the adipose tissue was removed from the patient.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A method of treating a patient comprising:
(a) providing a tissue removal system; (b) removing adipose tissue from a patient using the tissue removal system; (c) processing at least a part of the adipose tissue to obtain a concentration of stem cells other than the concentration of stem cells of the adipose tissue before processing; and (d) administering the stem cells to a patient without removing the stem cells from the tissue removal system before being administered to the patient.Join the waitlist — get patent alerts
Track US2016143952A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.